Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Type I interferon induces CXCL13 to support ectopic germinal center formation.

Denton AE, Innocentin S, Carr EJ, Bradford BM, Lafouresse F, Mabbott NA, Mörbe U, Ludewig B, Groom JR, Good-Jacobson KL, Linterman MA.

J Exp Med. 2019 Feb 5. pii: jem.20181216. doi: 10.1084/jem.20181216. [Epub ahead of print]

PMID:
30723095
2.

A Task Force Against Local Inflammation and Cancer: Lymphocyte Trafficking to and Within the Skin.

Lafouresse F, Groom JR.

Front Immunol. 2018 Oct 24;9:2454. doi: 10.3389/fimmu.2018.02454. eCollection 2018. Review.

3.

Plasmacytoid dendritic cell heterogeneity is defined by CXCL10 expression following TLR7 stimulation.

Marsman C, Lafouresse F, Liao Y, Baldwin TM, Mielke LA, Hu Y, Mack M, Hertzog PJ, de Graaf CA, Shi W, Groom JR.

Immunol Cell Biol. 2018 Nov;96(10):1083-1094. doi: 10.1111/imcb.12173. Epub 2018 Jun 25.

PMID:
29870118
4.

Friends help make lasting memories.

Lafouresse F, Groom JR.

Immunol Cell Biol. 2018 Apr;96(4):344-346. doi: 10.1111/imcb.12036. No abstract available.

PMID:
29687924
5.

L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo.

Lafouresse F, Bellard E, Laurent C, Moussion C, Fournié JJ, Ysebaert L, Girard JP.

Blood. 2015 Sep 10;126(11):1336-45. doi: 10.1182/blood-2015-02-626291. Epub 2015 Jul 10.

6.

Actin cytoskeleton control of the comings and goings of T lymphocytes.

Lafouresse F, Vasconcelos Z, Cotta-de-Almeida V, Dupré L.

Tissue Antigens. 2013 Nov;82(5):301-11. doi: 10.1111/tan.12193. Epub 2013 Sep 24. Review.

PMID:
24131017
7.

CIP4 controls CCL19-driven cell steering and chemotaxis in chronic lymphocytic leukemia.

Malet-Engra G, Viaud J, Ysebaert L, Farcé M, Lafouresse F, Laurent G, Gaits-Iacovoni F, Scita G, Dupré L.

Cancer Res. 2013 Jun 1;73(11):3412-24. doi: 10.1158/0008-5472.CAN-12-3564. Epub 2013 May 3.

8.

Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments.

Cougoule C, Van Goethem E, Le Cabec V, Lafouresse F, Dupré L, Mehraj V, Mège JL, Lastrucci C, Maridonneau-Parini I.

Eur J Cell Biol. 2012 Nov-Dec;91(11-12):938-49. doi: 10.1016/j.ejcb.2012.07.002. Epub 2012 Sep 19.

PMID:
22999511
9.

Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4+ T-cell motility by regulating adhesion to intercellular adhesion molecule-1.

Lafouresse F, Cotta-de-Almeida V, Malet-Engra G, Galy A, Valitutti S, Dupré L.

Immunology. 2012 Oct;137(2):183-96. doi: 10.1111/j.1365-2567.2012.03620.x.

10.

The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling.

Calvez R, Lafouresse F, De Meester J, Galy A, Valitutti S, Dupré L.

Haematologica. 2011 Oct;96(10):1415-23. doi: 10.3324/haematol.2011.040204. Epub 2011 Jun 9.

11.

Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.

Trifari S, Scaramuzza S, Catucci M, Ponzoni M, Mollica L, Chiesa R, Cattaneo F, Lafouresse F, Calvez R, Vermi W, Medicina D, Castiello MC, Marangoni F, Bosticardo M, Doglioni C, Caniglia M, Aiuti A, Villa A, Roncarolo MG, Dupré L.

J Allergy Clin Immunol. 2010 Feb;125(2):439-448.e8. doi: 10.1016/j.jaci.2009.11.034.

PMID:
20159256

Supplemental Content

Loading ...
Support Center